A clinical trial for patients with high-grade neuroendocrine tumors is now open for enrollment at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine. High-grade neuroendocrine cancer is a complex and aggressive condition that has seen few medical advances, in part because its rarity has subdued research investment. Patients have few options beyond conventional chemotherapy.
New research from Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, scientists has found that targeting ZNF638, a “master regulator” protein that silences retroviruses, can induce an antiviral response in glioblastoma.
A UF researcher has launched a new clinical trial to test a novel UF-developed mRNA lipid nanoparticle (RNA-LP) that is designed to reprogram the immune system in two pediatric cancers.
When he retired to Sebring from Atlanta in 2014, Dennis Davis had a plan: fish and spend time with his wife, Deb. Despite ongoing treatment for prostate cancer and tongue cancer, the 75-year-old said he has been able to do that thanks to the ongoing care he’s received at Moffitt Cancer Center. It’s a two-plus hour drive to Tampa for his appointments, but he’s more than happy to make the trek, he said.
For cancers of organs like the liver, the long-term impact of our diet has been well studied — so much so that we have guidance about red meat, wine and other delicacies.
Immune checkpoint inhibitors have been a game-changer in oncology. Tumors often have proteins on them that tell your immune system not to attack. Checkpoint inhibitors — which work by blocking these proteins so your immune system continues to fight the tumor — have provided new options for many people with advanced or metastatic cancer who were left with limited options.
Adding one drug to a chemotherapy regimen for children with acute lymphoblastic leukemia decreased risk of relapse by about two-thirds, according to a study designed in part by John Kairalla, Ph.D., the senior statistician on the clinical trial and research associate professor and associate program director of the Children’s Oncology Group Statistics and Data Center in the College of Public Health and Health Professions’ Department of Biostatistics.
The Department of Radiation Oncology at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, has become the first in North America to obtain the prestigious International Stereotactic Radiosurgery Society (ISRS) Certification for stereotactic radiosurgery (SRS) treatments of malignant and benign brain disorders.
When Karen Wilford first battled breast cancer in 2008, her doctors ordered chemotherapy, radiation and surgery. She remembers being told she’d lose her hair and was given a wig and makeup to help her feel better. Things were noticeably different when the cancer returned as stage 4 a few years ago.
The community grants will support eight new and ongoing cancer screening and prevention projects this year.
